




Searching News Database: Grunenthal
HSMN NewsFeed - 14 Nov 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
HSMN NewsFeed - 1 Feb 2018
Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO
Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO
HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
HSMN NewsFeed - 17 Feb 2017
AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
HSMN NewsFeed - 25 Mar 2014
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer
HSMN NewsFeed - 16 Dec 2013
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
HSMN NewsFeed - 9 Jan 2007
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
HSMN NewsFeed - 9 May 2006
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium